Skip to main content


Log in

Stimulation of Innate and Adaptive Immune Cells with Graphene Oxide and Reduced Graphene Oxide Affect Cancer Progression

  • Review
  • Published:
Archivum Immunologiae et Therapiae Experimentalis Aims and scope


Sole nanomaterials or nanomaterials bound to specific biomolecules have been proposed to regulate the immune system. These materials have now emerged as new tools for eliciting immune-based therapies to treat various cancers. Graphene, graphene oxide (GO) and reduced GO (rGO) are the latest nanomaterials among other carbon nanotubes that have attracted wide interest among medical industry players due to their extraordinary properties, inert-state, non-toxic and stable dispersion in a various solvent. Currently, GO and rGO are utilized in various biomedical application including cancer immunotherapy. This review will highlight studies that have been carried out in elucidating the stimulation of GO and rGO on selected innate and adaptive immune cells and their effect on cancer progression to shed some insights for researchers in the development of various GO- and rGO-based immune therapies against various cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

reproduced from Silva et al. (2017) with permission from Elsevier

Fig. 3

taken from public domain and original source from National Cancer Institute, USA

Fig. 4

Similar content being viewed by others


Download references


This research was supported from research university individual grant from Universiti Sains Malaysia (1001/CIPPT/8012205).

Author information

Authors and Affiliations


Corresponding author

Correspondence to Rafeezul Mohamed.

Ethics declarations

Conflict of Interest

The authors declared no conflict interest in any form.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yunus, M.A., Ramli, M.M., Osman, N.H. et al. Stimulation of Innate and Adaptive Immune Cells with Graphene Oxide and Reduced Graphene Oxide Affect Cancer Progression. Arch. Immunol. Ther. Exp. 69, 20 (2021).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: